REGISTERED
on 26 Mar 2024
Last Applicant/ Owned by
501 2nd Avenue, Qiantang New District
Hangzhou
CN
310018
Serial Number
97086075 filed on 21st Oct 2021
Registration Number
7340469 registered on 26th Mar 2024
Correspondent Address
Ryan P. Hiler
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RANOK THERAPEUTICS
pharmaceutical preparations for the treatment of cancer, immune-inflammatory diseases, and central nervous system diseases; pharmaceutical preparations for the prevention of cancer, immune-inflammatory diseases, and central nervous system diseases
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations for the treatment of cancer, immune-inflammatory diseases, and central nervous system diseases; pharmaceutical preparations for the prevention of cancer, immune-inflammatory diseases, and central nervous system diseases
First Use Date in General
25th Oct 2023
First Use Date in Commerce
25th Oct 2023
Mark Details
Serial Number
No 97086075
Mark Type
No Service/Collective Mark
Attorney Docket Number
No RANOK-00002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 26th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 21st Feb 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 20th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 20th Feb 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 26th Jan 2024 | TEAS STATEMENT OF USE RECEIVED |
| 26th Jan 2024 | USE AMENDMENT FILED |
| 07th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Jul 2023 | SOU TEAS EXTENSION RECEIVED |